Surgical Treatment for Spinal Cord Injury

NCT ID: NCT01674764

Last Updated: 2020-05-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

297 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-11-30

Study Completion Date

2019-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite many years of research, an incomprehensible amount of scientific efforts worldwide and billions of dollars invested, no effective therapy resulting in major neurological or functional recovery is available to date for traumatic spinal cord injury (tSCI). Although there is increasing experimental evidence from animal models that surgical decompression of the spinal cord improves recovery after tSCI, clinical studies have not shown conclusive data yet. The main explanations for this lack of convincing evidence are relatively small sample sizes in previous studies, their predominantly retrospective nature, suboptimal measurement methods for the assessment of neurological deficits, and inappropriate recording and documentation of potential confounding factors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Although injuries to the spinal column represent a relatively small proportion of all traumatic injuries, spinal injuries have one of the highest impacts on functional outcomes and employment status. Even more than an injury of the spinal column, traumatic spinal cord injury (tSCI) is a devastating disorder severely affecting patients' physical and psychosocial well-being. The incidence of tSCI is estimated to be 11 to 53 new cases per million population per year.

This is a multi-center, prospective, observational cohort study to evaluate if early (≤ 12 hours after the tSCI) surgical decom¬pression is superior to late (\> 12 hours and \< 14 days after the tSCI) in improving neurologic motor outcomes in patients with acute traumatic spinal cord injury.

The study will enroll 300 patients with anticipated 1:2 ratio of early vs. late surgery. This CIP is not limited to cervical spinal cord injuries, does not consider a diagnostic MRI as mandatory and will be conducted in a European setting where patients are generally transported more swiftly to the treating institution when compared to other geographic regions in the world.

Patients will be evaluated according to the schedule set forth in this CIP. The schedule includes evaluations at pre-surgery, post-surgery, 72 hours post injury, 12 weeks ± 2 weeks; 6 months ± 30 days; 1 year ± 30 days. The enrollment period is expected to be approximately 36 months and subjects will be followed-up for 12 months for the evaluation of the primary endpoint. The study duration is approximately 48 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Spinal Cord Injury of Traumatic Origin (tSCI)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early surgical intervention = Cohort 1

≤ 12 hours after the tSCI

Early surgical intervention

Intervention Type PROCEDURE

Open surgical stabilization and decompression (anterior, posterior or circumferential); and/or Closed reduction and external fixation

Late surgical intervention = Cohort 2

\> 12 hours and \< 14 days after the tSCI

Late surgical intervention

Intervention Type PROCEDURE

Open surgical stabilization and decompression (anterior, posterior or circumferential); and/or Closed reduction and external fixation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early surgical intervention

Open surgical stabilization and decompression (anterior, posterior or circumferential); and/or Closed reduction and external fixation

Intervention Type PROCEDURE

Late surgical intervention

Open surgical stabilization and decompression (anterior, posterior or circumferential); and/or Closed reduction and external fixation

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

≤ 12 hours after the tSCI > 12 hours and < 14 days after the tSCI

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years and older
* Diagnosis of blunt spinal column injury and spinal cord injury, including conus medullaris and/or cauda equina injuries
* Pre-surgery ASIA grade A, B, C or D
* Less than 14 days between the injury and surgery
* Ability to understand patient information / informed consent form
* Willingness and ability to participate in the clinical investigation and FU procedures (FUs)
* Informed consent according to local legislations and applicable guidelines

Exclusion Criteria

* Traumatic brain injury: Glasgow Coma Scale (GCS) ≤ 13
* Diagnosis of subclinical or clinical polyneuropathy (eg. presence of bilateral impairment of strength, sensation, and/or deep tendon reflexes with symmetrical and distal distribution and/or neurophysiological abnormalities)
* Spinal cord injury caused by a penetrating injury
* Non-traumatic or pathologic fractures or cord compression (eg, tumor or infection)
* Unable to cooperate with physical examination (pre-operative, ≤ 2 weeks) because of cognitive impairment, as assessed by the examiner
* Previous spinal column or spinal cord injury
* Diagnosis of spondyloarthropathy (inflammatory or non-inflammatory)
* Morbid Obesity: Body Mass Index (BMI) \> 35
* Any severe systemic disease that may have an influence on motor function (eg, polyneuropathy)
* ASA classification score ≥ 4
* Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment
* Pregnancy at the time of inclusion
* Prisoner
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AOSpine Europe

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Allard JF Hosman, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Medical Co-Director Spine Unit, Radboud University Medical Centre, 6500 Nijmegen, The Netherlands

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University Innsbruck

Innsbruck, , Austria

Site Status

National Institute of Emergency Medicine "N.I. Pirogov"

Sofia, , Bulgaria

Site Status

Teaching Hospital Sisiters of Charity

Zagreb, , Croatia

Site Status

Hôspital P. Wertheimer

Lyon, , France

Site Status

BG Unfallklinik Frankfurt

Frankfurt, , Germany

Site Status

Berufsgenossenschaftliche Unfallklinik Ludwigshafen

Ludwigshafen, , Germany

Site Status

Mater Misericordiae University Hospital

Dublin, , Ireland

Site Status

Ospedale Maggiore

Bologna, , Italy

Site Status

Policlinico Umberto Primo

Rome, , Italy

Site Status

University Medical Center St. Radboud

Nijmegen, , Netherlands

Site Status

University Medical Center Utrecht

Utrecht, , Netherlands

Site Status

Spitalul "Sfanta Treime"

Iași, , Romania

Site Status

Clinical Center Vojvodina

Novi Sad, , Serbia

Site Status

Gazi University Faculty of Medicine

Ankara, , Turkey (Türkiye)

Site Status

King's College Hospital

London, , United Kingdom

Site Status

Queens's Medical Centre Campus

Nottingham, , United Kingdom

Site Status

Nuffield Orthopaedic Centre Headington

Oxford, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Bulgaria Croatia France Germany Ireland Italy Netherlands Romania Serbia Turkey (Türkiye) United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SCI-POEM

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safety Stem Cells in Spinal Cord Injury
NCT04205019 COMPLETED PHASE1
Stem Cell Therapy in Spinal Cord Injury
NCT02009124 WITHDRAWN PHASE2
Cranio-spinal Neurosurgical Approaches
NCT07287462 NOT_YET_RECRUITING
Stem Cells in Spinal Cord Injury
NCT03935724 UNKNOWN PHASE2/PHASE3
Spinal Cord Neuromodulation for Spinal Cord Injury
NCT02313194 ACTIVE_NOT_RECRUITING PHASE1/PHASE2
Spinal Cord Stimulation and Training
NCT05472584 RECRUITING NA